Individuals with Insulin Resistance: Even without a formal diabetes diagnosis, GLP-1 medications might be considered in cases of significant insulin resistance
Ongoing medical monitoring allows doctors to assess appetite response, side effect patterns, and overall progress
Neurosci Lett 165(12):208210 Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, OCallaghan JP (2002) Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinsons disease
The gastric slowing effect is modest, and appetite suppression is mild
Although these facilities are subject to stringent regulation, the medications themselves are not FDA-approved, as they are tailored to individual prescriptions for specific patients
Ticino F